Nicolas Girard, MD, PhD

Articles by Nicolas Girard, MD, PhD
Dr. Girard Discusses PALOMA-2 at 2024 American Society of Clinical Oncology Annual Meeting
Nicolas Girard, MD, PhDASCO 2024: Focus on Lung Cancer | June 12, 2024
The phase 2 trial evaluated subcutaneous amivantamab and lazertinib as a first-line therapy for EGFR-mutated NSCLC.
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |